Encephalopathy in COVID-19 Patients

Area of Science:

• Neurology
• Infectious Diseases
• Critical Care Medicine

Background:

• Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations, including severe neurological complications.
• Encephalopathy and encephalitis are serious central nervous system (CNS) complications associated with SARS-CoV-2 infection.

Observation:

• A 67-year-old male with COVID-19 pneumonia developed aphasia, hemiplegia, and hemiparesis.
• Brain imaging revealed acute necrotizing encephalopathy, attributed to an intracranial cytokine storm.
• Cerebrospinal fluid analysis in some cases has detected the virus.

Findings:

• Treatment with intravenous immunoglobulin (IVIG) and high-dose corticosteroids led to clinical improvement and reduced brain edema.
• Pathogenesis may involve hypoxia, metabolic changes from cytokine storm, and potential neurotropism of SARS-CoV-2.
• Characteristic MRI findings include symmetric, multifocal lesions, often involving the thalamus, brainstem, and white matter.

Implications:

• Early recognition and aggressive immune modulation are crucial for managing COVID-19-associated encephalopathy.
• Understanding the mechanisms of CNS involvement can guide therapeutic strategies for neurological complications of viral infections.
• This case underscores the importance of considering neurological assessments in severe COVID-19 cases.